<DOC>
	<DOCNO>NCT00306046</DOCNO>
	<brief_summary>18 F-fluoride Positron emission tomography ( PET ) able demonstrate quantify metabolic activity locally skeleton ( 1 ) . This technique , therefore , also able demonstrate dramatic decrease metabolic activity localize monostotic Paget ’ disease lesion therapy . In condition , indeed , usual biological marker may unhelpful assess efficacy therapy , usually comprise normal range single pagetic localization , even therapy ( 2 ) . The main purpose trial assess early long term response pagetic bone bisphosphonate therapy .</brief_summary>
	<brief_title>18F-Fluoride Positron Emission Tomography ( PET ) Paget 's Disease Bone</brief_title>
	<detailed_description>I . Background subject : Paget ’ disease bone condition characterize focal exuberant increase bone remodel , result number important architectural abnormality , potentially lead bone deformity bone fragility . This condition may polyostotic monostotic . Biological marker bone remodel , mainly alkaline phosphatase marker bone resorption urinary hydroxyproline , commonly utilized ass Paget ’ disease activity . However , monostotic Paget ’ disease frequently accompany biological marker still normal range ( 1 ) . Conventional 99mTc MDP bone scan able localize lesion . However , change observe technique therapy disease recur help much guide clinician ( 3 ) . Indeed , improvement conventional bone scan whereas X-ray film , worsen pagetic lesion might simultaneously observe ( 4 ) . The recurrence condition could also miss conventional bone scan ( 4 ) . Therefore , PET scan use 18 Fluoride metabolic approach able demonstrate local activity Paget ’ disease , assess efficacy active drug evidence local recurrence disease , good conventional exist technique . II . Experimental approach method 1 . 20 patient suffer Paget ’ disease bone ( polyostotic : n = 6 ; monostotic : n = 14 ) study prior 1 , 6 , 12 month bisphosphonate therapy . The polyostotic case serve preliminary feasibility study . A localized Paget ’ disease include isolate Pagetic lesion bone face skull , spine ( low upper ) limb . 2 . Paget ’ disease confirm X ray quantify biological parameter bone remodel : total alkaline phosphatase , bone specific alkaline phosphatase , serum C-telopeptide ( CTX ) , urinary NTx correct creatinine morning spot urine overnight fast . 3 . Routine biological parameter creatinine , full blood count , serum calcium , phosphate magnesium , well 25OH vitamin D , 1,25 ( OH ) 2 vitamin D iPTH also perform start therapy . A total duration 5 year consider completion whole study . 18 Fluoride produce cyclotron , localize Louvain-la-Neuve ( Belgium ) . 18F-fluoride produce 18O ( p , n ) 18F nuclear reaction bombard enrich H218O target proton . 185 Mbq 18F inject . 4 . Scans perform Siemens ECAT HR+ PET scanner . This machine consist 32 ring BGO ( bismuth germanium oxide ) detector ( 40.5x43.9x30 mm size ) yield 63 transverse slice ( 2.425 mm thickness ) 16.2 cm axial FOV . In 2D mode , resolution HR+ scanner typically 5.4 mm 5.0 mm FWHM 10 cm transaxial axial direction , respectively . A dynamic acquisition center pagetic bone perform 60 minute , start immediately tracer injection . Data reconstruct filtered backprojection iterative method , attenuation correction obtain transmission scan perform tracer injection . Dynamic acquisition allow u modelize tracer uptake calculate influx constant mean multi-compartmental analysis . Kinetic model show well discriminate normal , osteoporotic Pagetic bone ( Cook et al , SNM 2001 , Toronto ) assume small change bone metabolism therapy precisely assess kinetic modeling simple semi-quantitative index standardize uptake value ( SUV ) . Nevertheless , prospectively compare different model SUV measurement identify appropriate quantification method . Effective radiation dose equivalent 0.027 mSv/Mbq 18F-fluoride . Target organ urinary bladder wall ( due urinary excretion unbound fraction tracer ) estimate radiation dose 0.25 mGy/MBq . III . References 1 . Cook GJ , Lodge MA , Blake GM , Marsden PK , Fogelman I . Differences skeletal kinetics vertebral humeral bone measure 18 F-fluoride positron emission tomography postmenopausal woman . J Bone Miner Res 2000 ; 15 : 763-769 . 2 . Kanis JA , Gray RES . Long-term follow-up observation treatment Paget ’ disease bone . Clin Orthop 1987 ; 217 : 99-125 . 3 . Smith ML , Fogelman I , Ralston S et al . Correlation skeletal uptake 99mTc-diphosphonate alkaline phosphatase oral diphosphonate therapy Paget ’ disease . Metab Bone Dis Relat Res 1984 ; 5 : 167-170 . 4 . Merrick MV , Merrick JM . Observations natural history Paget ’ disease . Clin Radiol 1985 ; 36 : 169-174 . 5 . Vellenga CLJR , Pauwels EKJ , Bijvoet OLM et al . Scintigraphic aspect recurrence treat Paget ’ disease bone . J Nucl Med 1985 ; 54 : 273-281 . 6 . A. Nzeusseu Toukap , M. Lonneux , J. Installe , A. Bolle , G. Depresseux , J.P. Devogelaer . International Symposium National Association Relief Paget ’ Disease . St Catherine ’ college , 17-18 july 2003 , Oxford , UK . 18F-Fluoride Positron Emission Tomography : Preliminary assessment therapy Paget ’ Disease Bone .</detailed_description>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Patients monostotic form PDB ( attest plain Xrays 99mTc MDP bone scintigraphy ) Bone pain link Paget ’ disease Bisphosphonate therapy within year prior study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>PETScan</keyword>
	<keyword>Positron-Emission Tomography</keyword>
	<keyword>Bisphosphonate</keyword>
	<keyword>Biochemical Markers</keyword>
	<keyword>Paget 's Disease Bone ( monostotic polyostotic )</keyword>
</DOC>